Raymond James Downgrades Exact Sciences (EXAS) to Outperform
Tweet
Share
E-mailGet Alerts EXAS Hot Sheet
Price: $104.91 --0%
Rating Summary:
8 Buy, 27 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
8 Buy, 27 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Raymond James analyst Andrew Cooper downgraded Exact Sciences (NASDAQ: EXAS) from Strong Buy to Outperform with a price target of $130.00 (from $160.00).
For an analyst ratings summary and ratings history on Exact Sciences click here. For more ratings news on Exact Sciences click here.
Shares of Exact Sciences closed at $95.63 yesterday.
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- MDA Ltd (MDA:CN) (MDALF) PT Raised to Cdn$64 at CIBC
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
